Dataset: Expression data from peripheral blood lymphocytes of major depression, subsyndromal symptomatic depression, and healthy controls
Several studies have suggested that SSD is a transitory phenomena in the depression spectrum and is thus considered a subtype of...
Several studies have suggested that SSD is a transitory phenomena in the depression spectrum and is thus considered a subtype of depression. However, the pathophysioloy of depression remain largely obscure and studies on SSD are limited. The present study compared the expression profile and made the classification with the leukocytes by using whole-genome cRNA microarrays among drug-free first-episode subjects with SSD, MDD, and healthy controls. We used microarrays to detail the global programme of gene expression to develop blood-based gene expression profiles models for classification of subsyndromal symptomatic depression and major depressive disorder The present study compared the expression profile and made the classification with the leukocytes by using whole-genome cRNA microarrays among drug-free first-episode subjects with SSD, MDD, and matched controls (8 subjects in each group). Support vector machines (SVMs) were utilized for training and testing on candidate signature expression profiles from signature selection step.
- Species:
- human
- Samples:
- 37
- Source:
- E-GEOD-32280
- Updated:
- Dec.12, 2014
- Registered:
- Sep.16, 2014
Sample | DISEASE STATUS | TREATMENT |
---|---|---|
GSM799722 | MDD patient | before treatment |
GSM799722 | MDD patient | before treatment |
GSM799722 | MDD patient | before treatment |
GSM799722 | MDD patient | before treatment |
GSM799722 | MDD patient | before treatment |
GSM799727 | healthy control | not specified |
GSM799727 | healthy control | not specified |
GSM799727 | healthy control | not specified |
GSM799727 | healthy control | not specified |
GSM799727 | healthy control | not specified |
GSM799727 | healthy control | not specified |
GSM799727 | healthy control | not specified |
GSM799727 | healthy control | not specified |
GSM799735 | SSD patient | before treatment |
GSM799735 | SSD patient | before treatment |
GSM799737 | SSD patient | after treatment with Venlafaxine |
GSM799722 | MDD patient | before treatment |
GSM799739 | MDD patient | after treatment with Venlafaxine |
GSM799722 | MDD patient | before treatment |
GSM799739 | MDD patient | after treatment with Venlafaxine |
GSM799735 | SSD patient | before treatment |
GSM799722 | MDD patient | before treatment |
GSM799739 | MDD patient | after treatment with Venlafaxine |
GSM799739 | MDD patient | after treatment with Venlafaxine |
GSM799735 | SSD patient | before treatment |
GSM799737 | SSD patient | after treatment with Venlafaxine |
GSM799735 | SSD patient | before treatment |
GSM799737 | SSD patient | after treatment with Venlafaxine |
GSM799735 | SSD patient | before treatment |
GSM799737 | SSD patient | after treatment with Venlafaxine |
GSM799735 | SSD patient | before treatment |
GSM799739 | MDD patient | after treatment with Venlafaxine |
GSM799735 | SSD patient | before treatment |
GSM799737 | SSD patient | after treatment with Venlafaxine |
GSM799739 | MDD patient | after treatment with Venlafaxine |
GSM799739 | MDD patient | after treatment with Venlafaxine |
GSM799739 | MDD patient | after treatment with Venlafaxine |